Table 1.
Baseline characteristics
| Overall (n = 70) | RRH (n = 35) | LRH (n = 35) | p value | |
|---|---|---|---|---|
| Mean age (years) | 67.8 | 66.5 | 69.7 | 0.16 |
| Gender | ||||
| Male | 36 (51.4%) | 18 (51.4%) | 18 (51.4%) | 1.0 |
| Female | 34 (48.6%) | 17 (48.6%) | 17 (48.6%) | 1.0 |
| ASA grade | ||||
| I | 21 (30%) | 7 (20%) | 14 (40%) | 0.03 |
| II | 37 (52.9%) | 20 (57.1%) | 17 (48.6%) | 0.24 |
| III | 12 (17.1%) | 8 (22.9%) | 4 (11.4%) | 0.1 |
| BMI | ||||
| ≥ 30.0 kg/m2 | 22 (31.4%) | 17 (48.6%) | 5 (14.2%) | 0.001 |
| < 30 kg/m2 | 48 (68.6%) | 18 (51.4%) | 30 (85.8%) | 0.001 |
| Diagnosis | ||||
| Malignancy | 48 (68.6%) | 20 (57.1%) | 28 (80%) | 0.02 |
| Benign polyp | 17 (24.3%) | 10 (28.6%) | 7 (20%) | 0.2 |
| Crohn’s disease | 5 (7.1%) | 5 (14.3%) | 0 (0%) | 0.01 |
| Pathological T Stage (n = 48) | ||||
| T1 | 10 (20.8%) | 5 (25%) | 5 (17.9%) | 0.27 |
| T2 | 9 (18.8%) | 1 (5%) | 8 (28.6%) | 0.02 |
| T3 | 22 (45.8%) | 11 (55%) | 11 (39.3%) | 0.14 |
| T4 | 7 (14.6%) | 3 (15%) | 4 (14.2%) | 0.47 |
p values less than 0.05 was deemed statistically significant are highlighted in bold